According to the dolphin stock statistics, as of the closing, the stock price of Jiuzhou Pharmaceutical was 21.76 yuan, with a rise and fall of 3.62%, a turnover rate of 1.59%, and a transaction of 271 million yuan throughout the day.
01. Real-time funds
Today, the stock's main funds flowed in 67.89 million yuan, outflow of 87.78 million yuan, and net outflow of 19.89 million yuan, of which the net outflow of 6.052 million yuan was RMB 6.83 million, the net outflow of large orders was RMB 13.83 million, the net inflow of medium orders was RMB 13.62 million, and the net inflow of small orders was RMB 6.2673 million.
02. Industry ranking
The industry to which this stock belongs is the pharmaceutical manufacturing industry. A total of 84 companies in the industry rose, 124 companies fell, and the leading stock was Oriental Bio, with an increase of +13.76%. Judging from the ranking of the main net inflows in the sector, Jiuzhou Pharmaceutical today ranked 189th in the industry. Today, the main funds in the pharmaceutical manufacturing industry flowed in 19.725 billion yuan, outflowed outflows of 20.37 billion yuan, and the net outflow was 645 million yuan, with an overall increase and decline of -0.57%.
| ranking | name | rise and fall | main inflow | main outflow | main inflow | main inflow | main inflow | main inflow | transaction amount | |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Changchun Hi-Tech | +4.04% | 935 billion | 704 billion | 2 | 231 billion | 0 billion | 2 | 2. 12 | 1.504 billion |
| 2 | Hengrui Medicine | +1.12% | 1029 billion | 820 billion | 2 | 208 billion | 1769 billion | |||
| 3 | 1 Xinhecheng | +3.90% | 11.673 billion | .519 billion | .154 billion | 1.092 billion | ||||
| 4 | 1 Fosun Pharma | +2.58% | 1.061 billion | .965 billion | 956742 million | 1.963 billion | ||||
| 5 | Oriental Bio | +13.76% | 329 billion | 2 | 239 billion | 896063 million | 561 billion |
03. Funding trend
Jiuzhou Pharmaceutical cumulative rise and fall in the past 20 days was 9.24%, and the main force cumulative net outflow was 59.3335 million yuan during the period. As of today's closing, the total market value of Jiuzhou Pharmaceutical is 17.531 billion yuan.
| Time period | cumulative rise and fall | main cumulative net inflow | cumulative transaction amount |
|---|---|---|---|
| 3 days | 1.21% | -3740000000 | 834 billion |
| 5 days | 2.40% | 2.8666 million | 12.12htm111242 billion |
| 10 days | htm1110 days htm12htm1110 days htm12htm1110 days htm12htm1110 days htm12htm1110 days htm1110 days htm12htm1110 days l115.63%-815906 million | 2306 billion | |
| 20 | 9.24% | -593335 million | 4.693 billion |
04. Texture analysis
Main business of the company: The company is a high-tech pharmaceutical enterprise, mainly committed to providing CDMO one-stop service for domestic and foreign large and medium-sized pharmaceutical enterprises in research and development and production of innovative drugs; at the same time, it provides global chemical raw materials and pharmaceutical intermediates with innovative technology and commercial production business. .
As of December 31, 2019, Jiuzhou Pharmaceutical 's operating income was 2.017 billion yuan, and the net profit attributable to the parent company's shareholders was 238 million yuan, an increase of 51.32% year-on-year.
No institution has conducted research on Jiuzhou Pharmaceutical in the past three months, and the stock has received low attention from institutions.
Click to download the Dolphin Stock APP, and the smart market-oriented free experience for life
Disclaimer: The information provided on this page is for investors' reference only and does not constitute any investment advice.
